TrialInvestigational new drugs2007

A phase II clinical trial of ZD1839 (Iressa) in combination with docetaxel as first-line treatment in patients with advanced breast cancer.

Sheri K Dennison et al.PubMed ↗Publisher ↗

No numbers read from the abstract.